Metastatic prostate cancer diagnosed by fine‐needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates
RL Cantley, X Wang, ZR Reichert… - Cancer …, 2023 - Wiley Online Library
Introduction The diagnosis of metastatic prostatic cancer (MPC) by fine needle aspiration
(FNA) can usually be rendered by typical cytomorphologic and immunohistochemical (IHC) …
(FNA) can usually be rendered by typical cytomorphologic and immunohistochemical (IHC) …
Prognostic impact of prior local therapy in castration-resistant prostate cancer
M Koura, M Shiota, S Ueda, T Matsumoto… - Japanese journal of …, 2021 - academic.oup.com
Objective This study aimed to reveal the prognostic values of prior local therapy in first-line
therapy using androgen receptor-axis targeting agents (abiraterone or enzalutamide) or …
therapy using androgen receptor-axis targeting agents (abiraterone or enzalutamide) or …